Misplaced Pages

Template:Antidepressants: Difference between revisions

Article snapshot taken from[REDACTED] with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 09:06, 3 January 2011 view sourceAnypodetos (talk | contribs)Autopatrolled, Extended confirmed users, Pending changes reviewers, Rollbackers39,350 editsm Simplify markup, replaced:  • →  • (260) using AWB← Previous edit Revision as of 03:37, 7 February 2011 view source Markustwofour (talk | contribs)253 editsm updated formatting in tca section for consistency and readabilityNext edit →
Line 62: Line 62:
| group3 = ] and ]s (TCAs/TeCAs) | group3 = ] and ]s (TCAs/TeCAs)
| abbr3 = TCAs | abbr3 = TCAs
| list3 = {{Navbox subgroup
⚫ | list3 = '''Tricyclics''': ] • ] • ] • ] • ] • ] • ] • ] • ] • ] • ] • ]/] • ] • ] • ] • ] • ] • ] • ] • ] • ] • ] • ] • ] • ] • ] • ] • ] • ] • ] • ] • ] • ] • ] • ] • ] • ] • ] • ] • ] • ] • ] • ] • ] • ] • ] • ]; '''Tetracyclics''': ] • ] • ] • ] • ] • ] • ] • ] • ] • ] • ] • ] • ] • ]

| group1 = <small>]</small>
⚫ | list1 = ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]/]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ];

| group2 = <small>]
| list2 = ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]&nbsp;• ]
}}


| group4 = ]s (MAOIs) | group4 = ]s (MAOIs)

Revision as of 03:37, 7 February 2011

Antidepressants (N06A)
Specific reuptake inhibitors (RIs), enhancers (REs), and releasing agents (RAs)
Template:Navbox subgroup
Receptor antagonists and/or reuptake inhibitors
Template:Navbox subgroup
Tricyclic and tetracyclic antidepressants (TCAs/TeCAs)
Template:Navbox subgroup
Monoamine oxidase inhibitors (MAOIs)
Nonselective: Irreversible: Benmoxin • Echinopsidine • Iproclozide • Iproniazid • Isocarboxazid • Mebanazine • Metfendrazine • Nialamide • Octamoxin • Phenelzine • Pheniprazine • Phenoxypropazine • Pivalylbenzhydrazine • Safrazine • Tranylcypromine; Reversible: Caroxazone • Paraxazone; MAOA-Selective: Irreversible: Clorgyline; Reversible: Amiflamine • Bazinaprine • Befloxatone • Befol • Brofaromine • Cimoxatone • Esuperone • Harmala Alkaloids (Harmine, Harmaline, Tetrahydroharmine, Harman, Norharman, etc) • Methylene Blue • Metralindole • Minaprine • Moclobemide • Pirlindole • Sercloremine • Tetrindole • Toloxatone • Tyrima; MAOB-Selective: Irreversible: Ladostigil • Mofegiline • Pargyline • Rasagiline • Selegiline; Reversible: Lazabemide • Milacemide
Azapirones and other 5-HT1A receptor agonists
Alnespirone • Aripiprazole • Befiradol • Buspirone • Eptapirone • Flesinoxan • Flibanserin • Gepirone • Ipsapirone • Oxaflozane • Tandospirone • Vilazodone • Zalospirone
Dietary supplements (vitamins, minerals, amino acids, etc)
Ascorbic acid (Vitamin C) • Fish oil • Folic acid (Vitamin B9) • L-5-HTP (Oxitriptan) • L-DOPA (Levodopa) • L-Methionine • L-Phenylalanine • L-Tryptophan • L-Tyrosine • Lithium • Magnesium • Melatonin • Niacin/Niacinamide (Vitamin B3) • Omega-3 fatty acids • Pyridoxine (Vitamin B6) • Rubidium • SAMe • Zinc
Research compounds and miscellaneous agents
Template:Navbox subgroup
Index of psychology and psychiatry
Description
Disorders
Treatment
How to manage this template's collapsible groups/sections option
  • This template includes collapsible groups/sections. When it first appears, one of these groups/sections may be set to be visible ("expanded") while the others remain hidden ("collapsed") apart from their titlebars. To achieve this, include the parameter |name where name is one of the following words that identify the groups/sections (omit any speech or quotation marks):
  • "RIEAs", "RARIs", ""TCAs", "MAOIs", "AZPs", "SUPPs" or "MISCs"
Category:
Template:Antidepressants: Difference between revisions Add topic